POAI — Predictive Oncology Cashflow Statement
0.000.00%
Last trade - 00:00- $49.22m
- $48.98m
- $1.62m
Annual cashflow statement for Predictive Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -25.9 | -19.7 | -25.7 | -14 | -12.7 |
| Depreciation | |||||
| Non-Cash Items | 13.8 | 7.3 | 11.2 | 1.33 | 1.46 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.21 | -1.19 | 0.867 | -0.78 | -0.915 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -12.3 | -12.2 | -12.4 | -13.2 | -12 |
| Capital Expenditures | -0.361 | -0.962 | -0.476 | -0.048 | -0.01 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.193 | -9.65 | 0 | -0.255 | 0.032 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.167 | -10.6 | -0.476 | -0.302 | 0.022 |
| Financing Cash Flow Items | -0.222 | -5.36 | 0 | 0 | -0.871 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13 | 50.3 | 6.72 | 0.149 | 3.94 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.527 | 27.5 | -6.13 | -13.3 | -7.99 |